BioSpace News Archive

Paratek Pharmaceuticals, Inc. announced that on March 31, 2022, the Company granted stock options and restricted stock units to ten new employees of the Company.

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that the Company approved the grant of stock options to purchase an aggregate of 58,600 shares of Karyopharm’s common stock and an aggregate of 36,900 restricted stock units to six newly-hired employees.

Syros Pharmaceuticals, a leader in the development of medicines that control the expression of genes, announced the grant of restricted stock unit awards for an aggregate of 89,400 shares of Syros common stock to three newly hired employees in connection with their commencement of employment with Syros.

MEI Pharma, Inc., a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced the grant of inducement stock options for an aggregate of 295,000 shares of the company’s common stock to four new employees.

Legend Biotech Corporation today announced the appointment of Guowei Fang, Ph.D., as Senior Vice President, Global Head of Research and Early Development.

TCR2 Therapeutics Inc. announced that on March 31, 2022, the Compensation Committee of the Board of Directors of TCR2’s approved the grant of inducement stock options covering an aggregate of 73,000 shares of TCR2’s common stock to 9 new non-executive employees.

G1 Therapeutics, Inc. announced the grant of inducement stock options exercisable for an aggregate of 25,800 shares of G1’s common stock and an aggregate of 11,200 restricted stock units to four hired employees under the Amended and Restated G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Adicet Bio, Inc. today announced it granted inducement awards on March 31, 2022 (the “Grant Date”) under Adicet’s 2022 Inducement Plan as a material inducement to employment to two individuals hired by Adicet in March 2022.

Oncternal Therapeutics, Inc. announced that it has granted an inducement award to one new employee, Rachel Monet Kenny, who joined the Company as Associate Director, CMC and Clinical Supply Chain.